GUFIC BIOSCIENCES LTD. - 509079 - Statement Of Related Party Transactions For Half Year Ended March 31, 2019
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of disclosure pertaining to Related Party Transactions of the Company for the half year ended March 31, 2019. Gufic Biosciences Ltd - 509079 - Statement Of Related Party Transactions For Half Year Ended March 31, 2019
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of disclosure pertaining to Related Party Transactions of the Company for the half year ended March 31, 2019. Gufic Biosciences Ltd - 509079 - Closure of Trading Window
Pursuant to the National Stock Exchange of India Limited (NSE) letter dated 2nd April, 2019 vide Ref. No: NSE/CML/2019/11 and in accordance with the Company''s Code of Conduct, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) . Regulations, 2015, please be informed that the trading window shall be closed for dealing in the securities of the Company for all the Insiders (including Directors and Connected/ Designated Persons and their immediate relatives) of the Company from Monday, July 01, 2019. The trading window will re-open 48 hours from the announcement to the Stock Exchanges of the Unaudited Financial Results of the Company for the quarter ended June 30, 2019. Kindly take the same on record. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Change in Directorate
The Board of Directors of the Company at its Meeting held on June 29, 2019, which commenced at 4.15 p.m and concluded at 4.50 p.m on June 29, 2019, inter alia considered and approved the following: 1. Appointment of Mr. Rabi Narayan Sahoo (DIN: 01237464) as an Additional Non-Executive Independent Director of the Company for a period of three years with effect from June 29, 2019, subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting. The brief profile of Mr. Rabi Narayan Sahoo is as below: Mr. Rabi Narayan Sahoo has done graduation in MD, pharmacology from AIIMS, New Delhi. In the year 1989, Dr Sahoo joined Cadila Laboratories as medical advisor. He then moved to Torrent Pharmaceuticals in 1993 and later in 1995, he joined Sun Pharma Industries Limited as a General Manager and he was in charge of regulatory affairs, clinical research and medical services. He left Sun pharma in 2002 to pursue his interest as Senior Consultant in pharma industry. He has been associated with Centaur pharmaceuticals and many reputed companies in the past. Mr. Rabi Narayan Sahoo have no inter-se relationship with the Directors of the Company. Kindly take the same on record. GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Intimation for Outcome Of The Board Of Directors Meeting Held On June 29, 2019
GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2019 ,inter alia, to consider and approve The Board of Directors of the Company at its Meeting held on June 29, 2019, which commenced at 4.15 p.m and concluded at 4.50 p.m on June 29, 2019, inter alia considered and approved the following: 1. Appointment of Mr. Rabi Narayan Sahoo (DIN: 01237464) as an Additional Non-Executive Independent Director of the Company for a period of three years with effect from June 29, 2019, subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting. Mr. Rabi Narayan Sahoo have no inter-se relationship with the Directors of the Company. Kindly take the same on record. GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform you that we are in receipt of the information about the loss of share certificate received from one of the shareholder by our RTA M/s. Link Intime (India) Private Limited. You are requested to kindly take the same on record. Gufic Biosciences Ltd - 509079 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform you that we are in receipt of the information about the loss of share certificate received from one of the shareholder by our RTA M/s. Link Intime (India) Private Limited. You are requested to kindly take the same on record. Gufic Biosciences Ltd - 509079 - Statement On Impact Of Audit Qualification.
Enclosed is the statement on Impact of Audit Qualification for the Financial Year 2018-19. You are requested to kindly take the same on record. Gufic Biosciences Ltd - 509079 - Results - Financial Results For Quarter And Year Ended March 31, 2019
The Board of Directors of the Company at its Meeting inter alia considered and approved the Audited Financial Results for the quarter and year ended March 31, 2019. Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (''Listing Regulations''), enclosed is the said results together with the Auditors Report. Kindly take the same on your record.